1 Department of Chemistry and Biochemistry, Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN 46617, USA. Sharon.Stack.11@nd.edu.
2 Harper Cancer Research Institute, A200 Harper Hall, University of Notre Dame, South Bend, IN 46617, USA. Sharon.Stack.11@nd.edu.
3 Cell, Molecular and Cancer Biology Program, Medical Sciences, Indiana University School of Medicine, Bloomington, IN 47405, USA. knephew@indiana.edu.
4 Department of Cellular and Integrative Physiology and Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. knephew@indiana.edu.
5 Indiana University Simon Cancer Center, Indianapolis, IN 46202, USA. knephew@indiana.edu.
6 Department of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago, IL 60607, USA. joannab@uic.edu.
7 Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47401, USA. anmitra@indiana.edu.
8 Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA. anmitra@indiana.edu.
9 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. anmitra@indiana.edu.
The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor micro-environment (TME) consisted of reviews contributed by leaders in the ovarian cancer (OC) field. [...].